Search

everythinglearnresearchcommunity

for

Search:↓

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

The treatment was effective for advanced non-Hodgkin's lymphomas.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Ruby laser treatment is effective and well-tolerated for reducing hair growth.

Enhancing Tregs can protect against alopecia areata.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Erlotinib can cause excessive eyelash growth.

Activating certain cells in hair follicles can prevent hair loss caused by cancer treatments.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Removing both ovaries treated the woman's excess male hormone symptoms.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Cancer prevention has advanced significantly, with some strategies proving successful.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.